Clinical Trials Sponsored by Felix Bohm

Total 73 results

Hospital Felix Bulnes

Completed

Efficacy of the "Start to Move" Protocol on Functionality, Delirium and Acquired Weakness in ICU (STM)

Mechanical Ventilation Complication | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Intensive Care Unit Delirium | Intensive Care Neuropathy

Chile
HOHM Foundation

Not yet recruiting

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil (HOHM)

Silicosis

United States
Felix Bohm
Uppsala University; The Swedish Research Council; Boston Scientific Corporation; Abbo... and other collaborators

Completed

Ffr-gUidance for compLete Non-cuLprit REVASCularization (FULL REVASC)

Coronary Artery Disease | ST-elevation Myocardial Infarction

Sweden
Aelix Therapeutics

Completed

Safety and Immunogenicity Study of DNA.HTI, MVA.HTI and ChAdOx1.HTI in HIV-1-positive Patients (AELIX-002)

HIV

Spain
Felix JF Herth

Unknown

Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome)

Obstructive Chronic Bronchitis
Helix Medical Systems

Terminated

Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis

Breast Cancer

Israel
University Department of Geriatric Medicine FELIX...

Completed

Prevalence of Sarcopenia in Geriatric Patients

Sarcopenia

Switzerland
Telix International Pty Ltd

Recruiting

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Soft Tissue Sarcoma | Cervical Cancer | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Glioblastoma Multiforme | Non Small Cell Lung Cancer | Cholangiocarcinoma | Epithelial Ovarian Cancer | Head and Neck Squamous Cell Carcinoma and other conditions

United States
Telix International Pty Ltd

Recruiting

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2)

Glioblastoma | Glioblastoma Multiforme | Neoplastic Disease

Australia, Austria, Netherlands, New Zealand
Helix BioPharma Corporation
Theradex

Recruiting

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Pancreas Cancer

United States
Telix International Pty Ltd

Completed

Evaluation of Safety, Biodistibution and Sensitivity/Specificity of PET/CT Imaging With 89Zr-TLX250 in Subjects With RCC (ZIRDAC-JP)

Carcinoma, Renal Cell | Clear Cell Renal Cell Carcinoma

Japan
University Department of Geriatric Medicine FELIX...

Not yet recruiting

Combining Nutrition Supplementation With an Exercise Program in Elderly Malnourished Frail Patients After Hospital Stay

Frailty | Sarcopenia | Malnutrition; Protein
University Department of Geriatric Medicine FELIX...

Not yet recruiting

SARCOPEDIA - Sarcopenia Diagnostics in Aging Medicine (SARCOPEDIA)

Muscle Weakness | Frailty | Sarcopenia
University Department of Geriatric Medicine FELIX...

Completed

Power Centering for Seniors (PCS)

Healthy Aging | Mobility Limitation | Walking, Difficulty

Switzerland
Felix Ratjen

Completed

Tracking CF Lung Disease Through the Early Years: Utility of the LCI (LCITRACK)

Observational

Canada
Telix International Pty Ltd

Completed

177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study (ProstACTSelect)

Metastatic Prostate Cancer

Australia
Aelix Therapeutics
Gilead Sciences

Completed

Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients (AELIX-003)

HIV/AIDS

Spain
Telix Pharmaceuticals (Innovations) Pty Ltd

Recruiting

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only (PROSTACT)

Metastatic Prostate Cancer

Australia, New Zealand
Helix BioPharma Corporation
Theradex

Terminated

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Non-Small Cell Lung Cancer

United States
Telix International Pty Ltd

Completed

131I-IPA and Concurrent XRT in Recurrent GBM (IPAX-1)

Glioblastoma Multiforme

Austria, Australia, Netherlands
Rebecka Ohm

Recruiting

Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy

Facial Palsy | Bell Palsy | Facial Paralysis | Synkinesis | Peripheral Facial Palsy | Peripheral Facial Paralysis

Sweden
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study (89ZR-TLX250)

Clear Cell Renal Cell Carcinoma

United Kingdom, United States, Australia, Turkey, Netherlands, Belgium, Canada, France
Felix Liebau
Karolinska University Hospital; Karolinska Institutet

Not yet recruiting

Nutrient Uptake During Continuous Enteral Feeding

Critical Illness
Telix Pharmaceuticals (Innovations) Pty Limited

Active, not recruiting

External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)

Prostate Cancer

Australia
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) (CUPID)

Metastatic Prostate Cancer

Australia
Telix Pharmaceuticals (Innovations) Pty Limited

Available

89Zr-DFO-girentuximab Expanded Access Program (EAP)

Clear Cell Renal Cell Carcinoma

United States
Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

SARS-CoV-2

United States
Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

SARS-CoV-2

United States
Helix BioPharma Corporation
KCR S.A.

Terminated

A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma

Lung Adenocarcinoma

Poland, Ukraine
Felix Mueller
University of Bern

Not yet recruiting

LSD Treatment for Persons With Alcohol Use Disorder (LYSTA)

Alcohol Use Disorder (AUD)

Switzerland
BAMF Health
Telix International Pty Ltd

Recruiting

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Metastatic Castration-resistant Prostate Cancer

United States
Helix BioPharma Corporation
Pharm-Olam International

Completed

A Phase I/II Open-Label, Non-Randomized Dose Escalation Study of Immunoconjugate L-DOS47

Non-Small Cell Lung Cancer

Poland
University Department of Geriatric Medicine FELIX...
University of Basel

Terminated

Effect of Lyra Gait Training on the Mobility of Geriatric Rehabilitation Inpatients

Muscle Weakness | Mobility Limitation

Switzerland
Charite University, Berlin, Germany
Prof. Dr. Felix Bermpohl, Co-PI

Completed

Modification of Alternative Reward Cue Reactivity and Cognitive Control Through Physical Activity in Human Tobacco Use Disorder

Healthy | Tobacco Use Disorder

Germany
M.D. Anderson Cancer Center
Telix Pharmaceuticals Limited

Active, not recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Clear Cell Renal Cell Carcinoma | Advanced Cancer

United States
Fenix Innovation Group
Monash Health; Neurotech International

Not yet recruiting

Evaluating the Efficacy of NTI164 in Young People With Autism Spectrum Disorder

Autism Spectrum Disorder

Australia
Memorial Sloan Kettering Cancer Center
Telix Pharmaceutical

Active, not recruiting

Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma

Renal Cancer

United States
Fenix Innovation Group
Monash Health; Neurotech International

Active, not recruiting

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Autism Spectrum Disorder

Australia
Felix Mueller
Swiss Society for Psycholytic Therapy (SÄPT)

Enrolling by invitation

The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training (TherPsySE)

Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD

Switzerland
The Center for Applied Health Sciences, LLC
Biohm Health, LLC

Completed

A Probiotic Blend Reduces Gastrointestinal Symptoms and Positively Impacts Microbiota Modulation in a Randomized Study

Constipation | Microbiota | Candida

United States
The Center for Applied Health Sciences, LLC
Biohm Health, LLC

Completed

Effects of Pea Proteins on Muscle Damage and Recovery

Muscle Damage | Pea Proteins | Amino Acid Change

United States
Ranbaxy Laboratories Limited
Ohm Laboratories, Inc.

Completed

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

Healthy

United States
University Department of Geriatric Medicine FELIX...
University of Basel; Velux Stiftung

Recruiting

Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium (QumPreFall)

Fall | Delirium in Old Age | Delirium Superimposed on Dementia | Bed Falls

Switzerland
Institut Cancerologie de l'Ouest
Telix Pharmaceutical; SIRIC ILIAD

Recruiting

Imaging Performance Assessment of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Metastatic Triple Negative Breast Cancer Patients (OPALESCENCE)

Triple Negative Breast Cancer

France
Felix Chikita Fredy, MD
National Cardiovascular Center Harapan Kita Hospital Indonesia

Unknown

Effect of Doxycycline on Cardiac Remodelling in STEMI Patients

Heart Failure | ST Elevation Myocardial Infarction | Anterior Wall Myocardial Infarction | Remodeling, Ventricular

Indonesia
South Metropolitan Health Service
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients (ZiPUP)

Urothelial Carcinoma

Australia
Dalin Tzu Chi General Hospital
Felix Leung, MD, Sepulveda Ambulatory Care Center, VAGLAHS

Unknown

Comparing Maximal and Half-maximal Suction Pressure Applied During Water Exchange in Colonoscopy

Minimally Sedated Patient Undergoing Colonoscopy

Taiwan
Telix Pharmaceuticals (Innovations) Pty Limited
Merck KGaA, Darmstadt, Germany

Recruiting

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

Advanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell Carcinoma

Australia
Telix International Pty Ltd
Grand Pharmaceutical (China) Co., Ltd.

Completed

Evaluation of 89Zr-TLX250 PET/CT in Chinese Patients With Indeterminate Renal Masses or Suspected Recurrent Renal Clear Cell Carcinoma (ZIRDOSE-CP)

Clear Cell Renal Cell Carcinoma | Recurrent Renal Cell Cancer | Suspected Recurrent Renal Clear Cell Carcinoma

China
Radboud University Medical Center
ABX CRO; Telix International Pty Ltd

Completed

89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSE

Clear Cell Renal Carcinoma

Netherlands

Clinical Trials Sponsored by Felix Bohm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations